These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20110608)

  • 21. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS
    Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L
    Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.
    Sakamoto J; Kimura H; Moriyama S; Odaka H; Momose Y; Sugiyama Y; Sawada H
    Biochem Biophys Res Commun; 2000 Nov; 278(3):704-11. PubMed ID: 11095972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
    Yamamoto Y; Ono T; Dhar DK; Yamanoi A; Tachibana M; Tanaka T; Nagasue N
    J Gastroenterol Hepatol; 2008 Jun; 23(6):930-7. PubMed ID: 18565023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.
    Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertens Res; 2008 Jan; 31(1):117-25. PubMed ID: 18360026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
    Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
    Lahiri S; Sen T; Palit G
    Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
    Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
    Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes.
    Dello Russo C; Gavrilyuk V; Weinberg G; Almeida A; Bolanos JP; Palmer J; Pelligrino D; Galea E; Feinstein DL
    J Biol Chem; 2003 Feb; 278(8):5828-36. PubMed ID: 12486128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabonomic profiling revealed an alteration in purine nucleotide metabolism associated with cardiac hypertrophy in rats treated with thiazolidinediones.
    Liu Y; Yan X; Mao G; Fang L; Zhao B; Liu Y; Tang H; Wang N
    J Proteome Res; 2013 Dec; 12(12):5634-41. PubMed ID: 24164426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking.
    Stopponi S; Somaini L; Cippitelli A; Cannella N; Braconi S; Kallupi M; Ruggeri B; Heilig M; Demopulos G; Gaitanaris G; Massi M; Ciccocioppo R
    Biol Psychiatry; 2011 Apr; 69(7):642-9. PubMed ID: 21276964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.
    Gensch C; Clever YP; Werner C; Hanhoun M; Böhm M; Laufs U
    Atherosclerosis; 2007 May; 192(1):67-74. PubMed ID: 16876172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms.
    Schaefer KL; Denevich S; Ma C; Cooley SR; Nakajima A; Wada K; Schlezinger J; Sherr D; Saubermann LJ
    Inflamm Bowel Dis; 2005 Mar; 11(3):244-52. PubMed ID: 15735430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
    Hazra S; Batra RK; Tai HH; Sharma S; Cui X; Dubinett SM
    Mol Pharmacol; 2007 Jun; 71(6):1715-20. PubMed ID: 17412838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pioglitazone, a PPARγ Agonist, Upregulates the Expression of Caveolin-1 and Catalase, Essential for Thyroid Cell Homeostasis: A Clue to the Pathogenesis of Hashimoto's Thyroiditis.
    Werion A; Joris V; Hepp M; Papasokrati L; Marique L; de Ville de Goyet C; Van Regemorter V; Mourad M; Lengelé B; Daumerie C; Marbaix E; Brichard S; Many MC; Craps J
    Thyroid; 2016 Sep; 26(9):1320-31. PubMed ID: 27324467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.
    Borsting E; Cheng VP; Glass CK; Vallon V; Cunard R
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F540-51. PubMed ID: 22169011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of 12/15-lipoxygenase antisense oligonucleotide on peroxisome proliferator-activated receptor γ translocation in primarily cultured cortical neurons after oxygen-glucose deprivation].
    Han J; Sun L; Liang H; Cheng Y
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(15):1179-83. PubMed ID: 24924720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.